ACC 2026 Clinical Insights: Advancing Cardiovascular Care
Explore concise, expert-led educational activities delivering the latest updates from ACC 2026. This series highlights emerging science, late-breaking data, and evolving treatment strategies across cardiovascular care. Gain practical insights into how new evidence is shaping clinical decision-making and improving patient outcomes.
1-4 of 4
- ACC 2026 Clinical Insights: Advancing Cardiovascular Care
Evolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV
Nicholas Marston, MD
- ACC 2026 Clinical Insights: Advancing Cardiovascular Care
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Florian Rader, MD
- ACC 2026 Clinical Insights: Advancing Cardiovascular Care
SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Joseph Rossano, MD
- ACC 2026 Clinical Insights: Advancing Cardiovascular Care
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Joseph Rossano, MD
